| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |